Mikkel Lundbech
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effect of hyperthermic intraperitoneal chemotherapy on thrombin generation and fibrinolysis.
Journal: International journal of colorectal disease
Published: May 19, 2025
Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Surgery.
Journal: Thrombosis and haemostasis
Published: September 11, 2024
Extent of peritoneal metastases from colorectal cancer is not associated with changes in thrombin generation or fibrinolysis.
Journal: Pleura and peritoneum
Published: June 17, 2024
Changes in Coagulation in Cancer Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Treatment (HIPEC)-A Systematic Review.
Journal: Seminars in thrombosis and hemostasis
Published: February 24, 2023
Corrigendum to "Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1+2 as biomarkers for hypercoagulability in cancer patients" [Thromb. Res. 186 2020. 80-85].
Journal: Thrombosis research
Published: December 08, 2021
Postoperative bleeding and venous thromboembolism in colorectal cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis.
Journal: International journal of colorectal disease
Published: August 25, 2021
Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1+2 as biomarkers for hypercoagulability in cancer patients.
Journal: Thrombosis research
Published: July 31, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026